Breaking News Instant updates and real-time market news.

CBS

CBS

, VIAB

Viacom

$36.00

0.18 (0.50%)

09:28
10/17/16
10/17
09:28
10/17/16
09:28

CBS price target raised to $73 from $65 at Wedbush

Wedbush analyst James Dix says that CBS (CBS) is on track to merge with Viacom (VIAB), and he thinks that such a deal would be accretive to CBS' 2020 EPS. The analyst sees a 75% chance of a merger taking place, and he thinks that CBS' stock will advance even without a deal. He keeps a Buy rating on the shares.

CBS

CBS

VIAB

Viacom

$36.00

0.18 (0.50%)

CBS CBS

10/04/16
10/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CBS (CBS) upgraded to Buy from Sell at UBS with analyst Doug Mitchelson saying he sees any deal with Viacom (VIA) as priced into CBS shares already. He also has increased confidence in consensus estimates for CBS and sees further upside if the national TV ad market and CBS' ratings remain strong. 2. Pandora (P) upgraded to Conviction Buy from Buy at Goldman with analyst Heath Terry saying he sees significant upside to out-year estimates from premium radio and on-demand subscriptions. He expects competition to ease as new entrants slow and existing providers focus on profitability and limit "free" models. 3. Las Vegas Sands (LVS) upgraded to Buy from Neutral at BofA/Merrill with analyst Shaun Kelley saying shares remain fairly under-owned and thinks estimate revisions will move higher due to market momentum, better ROI for Parisian, Cotai infrastructure additions, and optionality from Japan and real estate. 4. KBR (KBR) upgraded to Buy from Hold at Deutsche Bank with analyst Chad Dillard saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. 5. West Marine (WMAR) upgraded to Buy from Neutral at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/13/16
WELS
10/13/16
UPGRADE
WELS
Market Perform
Viacom upgraded to Market Perform from Underperform at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded Viacom (VIAB) to Market Perform saying she believes shares are close to a floor. A merger with CBS (CBS) does not appear imminent, but if/when it does happen, CBS is unlikely to pay less than $32-$33 per Viacom share in a take-under, Ryvicker tells investors in a research note. The analyst has a $33-$35 price target range for Viacom shares. Ryvicker says that she still "REALLY" likes CBS and is cautious on CBS and Disney (DIS) into the Q3 earnings season.
10/14/16
RBCM
10/14/16
NO CHANGE
RBCM
CBS outlook positive says RBC Capital
RBC Capital analyst Steven Cahall expects CBS (CBS) to report "squeaky clean" Q3 results that includes a 1c EPS beat. The analyst is upbeat on a potential acquisition of Viacom (VIAB) by CBS, saying that the recent decline in Viacom's stock would improve accretion to CBS shareholders.
10/17/16
WEDB
10/17/16
UPGRADE
Target $46
WEDB
Outperform
Viacom upgraded to Outperform from Neutral at Wedbush
Wedbush analyst James Dix upgraded Viacom (VIAB) to Outperform citing increasing likelihood of a merger with CBS (CBS). The analyst assigns a 75% probability on a merger, which he assumes would be an all-stock transaction. He raised his price target for Viacom shares to $46 from $40.
VIAB Viacom
$36.00

0.18 (0.50%)

10/13/16
10/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Buy from Neutral at BofA/Merrill with analyst Colin Bristow citing its opportunity in first line lung cancer. 2. Viacom (VIA, VIAB) upgraded to Market Perform from Underperform at Wells Fargo and to Buy from Underperform at BofA/Merrill. 3. TD Ameritrade (AMTD) and Charles Schwab (SCHW) were upgraded to Buy from Neutral at BofA/Merrill. 4. Talend (TLND) upgraded to Buy from Neutral at Goldman with analyst Jesse Hulsing saying the company will benefit from analytic workloads moving to the cloud. 5. CSC (CSC) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/16
WEDB
10/17/16
DOWNGRADE
Target $90
WEDB
Neutral
Time Warner downgraded to Neutral from Outperform at Wedbush
Wedbush analyst James Dix downgraded Time Warner (TWX) to Neutral citing valuation with the stock up 23% year-to-date. The analyst keeps a $90 price target for the shares. He coupled the downgrade with an upgrade this morning of Viacom (VIAB) to Outperform.

TODAY'S FREE FLY STORIES

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:06
06/28/17
06/28
08:06
06/28/17
08:06
Earnings
Breaking Earnings news story on Monsanto »

Monsanto reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:05
06/28/17
06/28
08:05
06/28/17
08:05
Earnings
Monsanto reports Q3 EPS $1.90, consensus $1.76 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CBI

CB&I

$20.03

5.63 (39.10%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
CB&I awarded contract by Shurtan Gas Chemical Complex »

CB&I announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMNX

Luminex

$20.92

-0.3 (-1.41%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
Luminex receives CE-IVD mark for ARIES Norovirus Assay »

Luminex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

NVIV

InVivo Therapeutics

$2.75

0.2 (7.84%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
InVivo Therapeutics reports two patients in study improve in INSPIRE assessments »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MSA

MSA Safety

$79.73

0.44 (0.55%)

08:03
06/28/17
06/28
08:03
06/28/17
08:03
Hot Stocks
MSA Safety to acquire Globe Holding Company for $215M in cash »

MSA Safety announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Holdings

$86.01

-0.61 (-0.70%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Initiation
HCA Holdings initiated  »

HCA Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$87.90

0.08 (0.09%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Upgrade
State Street rating change  »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

OLN

Olin Corp.

$29.31

0.29 (1.00%)

07:58
06/28/17
06/28
07:58
06/28/17
07:58
Recommendations
Olin Corp. analyst commentary  »

Cowen calls Olin Corp. a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$10.40

0.09 (0.87%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
Daseke analyst commentary  »

Daseke revenue synergies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRU

TransUnion

$43.52

-0.78 (-1.76%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
TransUnion analyst commentary  »

TransUnion guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

COST

Costco

$159.26

-0.94 (-0.59%)

, AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

07:56
06/28/17
06/28
07:56
06/28/17
07:56
Recommendations
Costco, Amazon.com analyst commentary  »

Costco weakness a buying…

COST

Costco

$159.26

-0.94 (-0.59%)

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 23

    Aug

PYPL

PayPal

$52.73

-1.01 (-1.88%)

07:55
06/28/17
06/28
07:55
06/28/17
07:55
Recommendations
PayPal analyst commentary  »

PayPal shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

07:55
06/28/17
06/28
07:55
06/28/17
07:55
General news
N.Y. FX Outlook »

N.Y. FX Outlook: The…

BSX

Boston Scientific

$27.81

0.09 (0.32%)

07:53
06/28/17
06/28
07:53
06/28/17
07:53
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ADMA

ADMA Biologics

$4.06

0.46 (12.78%)

07:50
06/28/17
06/28
07:50
06/28/17
07:50
Recommendations
ADMA Biologics analyst commentary  »

Biotest deal gives ADMA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CKH

Seacor

$32.49

0.19 (0.59%)

07:49
06/28/17
06/28
07:49
06/28/17
07:49
Recommendations
Seacor analyst commentary  »

Seacor divestment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUSA

Murphy USA

$72.01

-0.44 (-0.61%)

07:48
06/28/17
06/28
07:48
06/28/17
07:48
Recommendations
Murphy USA analyst commentary  »

Murphy USA a top pick for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$6.14

-0.16 (-2.54%)

07:48
06/28/17
06/28
07:48
06/28/17
07:48
Hot Stocks
Ziopharm initiates stereotactic arm of Ad-RTS-hIL-12 + veledimex Phase 1 study »

Ziopharm announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVA

Sinovac Biotech

$6.34

-0.07 (-1.09%)

07:46
06/28/17
06/28
07:46
06/28/17
07:46
Hot Stocks
Sinobioway proposes $8 per share takeover of Sinovac Biotech »

The Shandong Sinobioway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$19.11

0.57 (3.07%)

07:46
06/28/17
06/28
07:46
06/28/17
07:46
Hot Stocks
Universal Stainless & Alloy reaches early labor agreement at Dunkirk facility »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$11.35

-0.12 (-1.05%)

07:45
06/28/17
06/28
07:45
06/28/17
07:45
Hot Stocks
Kratos Defense awarded UAV contract amendment by U.S. Navy »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
06/28/17
06/28
07:45
06/28/17
07:45
General news
U.S. MBA mortgage market index sank 6.2% »

U.S. MBA mortgage market…

PFIE

Profire Energy

$1.27

-0.0173 (-1.34%)

07:45
06/28/17
06/28
07:45
06/28/17
07:45
Conference/Events
Profire Energy management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

GRUB

GrubHub

$43.42

-1.22 (-2.73%)

, AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

07:42
06/28/17
06/28
07:42
06/28/17
07:42
Recommendations
GrubHub, Amazon.com analyst commentary  »

GrubHub should be bought…

GRUB

GrubHub

$43.42

-1.22 (-2.73%)

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.